Investor Vizirgianakis Stavros G.
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Vizirgianakis Stavros G. . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Date Form Target Prev
Shares
Current
Shares
Change
(Percent)
Ownership
(Percent)
Change
(Percent)
2025-06-12 13D 4,750,179
2024-05-09 13D/A APYX / Apyx Medical Corporation 1,746,191 1,746,191
2024-04-01 13D APYX / Apyx Medical Corporation 1,746,191
2022-09-06 13D XTNT / Xtant Medical Holdings, Inc. 7,224,924
2016-10-26 13D/A MSON / Misonix Inc 472,109 1,237,328
2016-09-01 13D/A MSON / Misonix Inc 472,109
2014-06-18 13D/A MSON / Misonix Inc 449,609
2013-05-10 13D/A MSON / Misonix Inc 380,100
2012-10-12 13D MSON / Misonix Inc 380,100